Riwang Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Riwang Li has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
Ningjian Ao
4 shared publicationsGang Wu
3 shared publicationsYi Liu
3 shared publicationsZhen Lin
3 shared publications- Dahai Liu
School of Medicine, Foshan University, Foshan, Guangdong, China
2 shared publications Daoqiang Lu
Foshan Univ, Sch Med, Foshan 528000, Guangdong, Peoples R China
2 shared publications
Latest Publications
- 19 January 2023
- Published by Elsevier in Materials Letters
- Vol. 336
Preparation of novel injectable photo-crosslinked collagen gels by a fast and simple method
- 19 January 2023
- Published by Elsevier in Materials Letters
- Vol. 336
Preparation of novel injectable photo-crosslinked collagen gels by a fast and simple method
- Open Access
- 7 January 2023
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 644, 140-148
Mst1 attenuates myocardial ischemia/reperfusion injury following heterotopic heart transplantation in mice through regulating Keap1/Nrf2 axis
- 7 January 2023
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 644, 140-148
Open AccessMst1 attenuates myocardial ischemia/reperfusion injury following heterotopic heart transplantation in mice through regulating Keap1/Nrf2 axis
- 1 September 2021
- Published by Elsevier in Composites Part B: Engineering
- Vol. 221
Injectable halloysite-g-chitosan hydrogels as drug carriers to inhibit breast cancer recurrence
- 1 September 2021
- Published by Elsevier in Composites Part B: Engineering
- Vol. 221
Injectable halloysite-g-chitosan hydrogels as drug carriers to inhibit breast cancer recurrence
- 17 August 2020
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 3 (9) , 6400-6407
PEGylated Bis-Quaternary Triphenyl-Phosphonium Tosylate Allows for Balanced Antibacterial Activity and Cytotoxicity
Quaternary triphenylphosphonium compound (TPP+) has been widely recognized as an important antimicrobial due to its fast antimicrobial speed, broad antimicrobial spectrum. However, small molecule TPP+ compounds have the defects of toxicity, which is the key factor that limits its practical applications. Here, two mono- and one bis-quaternary phosphonium tosylate compounds with different length of oligo(ethylene glycol) (OEG) chains and TPP+ as the active moiety were synthesized. Bis-TPP+ have short OEG chain coupling two TPP+ at both ends, while mono-TPP+ attach OEG chain at one end in one molecule. In vitro antibacterial activities were evaluated against both Gram-positive as well as Gram-negative bacteria in terms of inhibition zone (ZOI) and minimum inhibitory concentration (MIC). To investigate the antibacterial mechanism, β-galactosidase activity was monitored for measuring the degree of membrane permeability correlated to the abilities to disrupt the membranes of bacteria. Moreover, their structure-antibacterial activity and structure-cytotoxicity relationships were further analyzed. The results indicated that bis-TPP+ synthesized can reach the sterilization rate 90% or more against E. coli and S. aureus at the MIC of 3.1 mg/mL and 1.5 mg/ml, respectively and meanwhile the cell proliferation can reach more than 80%. This paper represents an excellent approach for development of bis-TPP+ bactericidal molecules that would achieve an optimal balance between antimicrobial activity and cytotoxicity.
- 17 August 2020
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 3 (9) , 6400-6407
PEGylated Bis-Quaternary Triphenyl-Phosphonium Tosylate Allows for Balanced Antibacterial Activity and Cytotoxicity
Quaternary triphenylphosphonium compound (TPP+) has been widely recognized as an important antimicrobial due to its fast antimicrobial speed, broad antimicrobial spectrum. However, small molecule TPP+ compounds have the defects of toxicity, which is the key factor that limits its practical applications. Here, two mono- and one bis-quaternary phosphonium tosylate compounds with different length of oligo(ethylene glycol) (OEG) chains and TPP+ as the active moiety were synthesized. Bis-TPP+ have short OEG chain coupling two TPP+ at both ends, while mono-TPP+ attach OEG chain at one end in one molecule. In vitro antibacterial activities were evaluated against both Gram-positive as well as Gram-negative bacteria in terms of inhibition zone (ZOI) and minimum inhibitory concentration (MIC). To investigate the antibacterial mechanism, β-galactosidase activity was monitored for measuring the degree of membrane permeability correlated to the abilities to disrupt the membranes of bacteria. Moreover, their structure-antibacterial activity and structure-cytotoxicity relationships were further analyzed. The results indicated that bis-TPP+ synthesized can reach the sterilization rate 90% or more against E. coli and S. aureus at the MIC of 3.1 mg/mL and 1.5 mg/ml, respectively and meanwhile the cell proliferation can reach more than 80%. This paper represents an excellent approach for development of bis-TPP+ bactericidal molecules that would achieve an optimal balance between antimicrobial activity and cytotoxicity.
- 25 March 2020
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 12 (15) , 17936-17948
Injectable and In Situ-Formable Thiolated Chitosan-Coated Liposomal Hydrogels as Curcumin Carriers for Prevention of In Vivo Breast Cancer Recurrence
In order to improve the water solubility and bioavailability, curcumin (Cur) was encapsulated by liposomes (Cur-Lip), which was further coated with thiolated chitosan (CSSH) to form liposomal hydrogels (CSSH/Cur-Lip Gel). The hydrogels were thermosensitive with in-situ injectable performance which were fluidic at room temperature and gelled quickly at 37 °C. The cumulative release ratio of 200 μM CSSH/Cur-Lip Gel were 31.57 ± 1.34 % at 12 h, which could effectively delay the release of curcumin. Worthily, the resilient hydrogels were compressive even after five cycles of compression. Cytotoxicity test indicated that the liposomal hydrogels had good cytocompatibility, but after encapsulation of curcumin, MCF-7 cells were suppressed and killed dramatically after 72 h. In vivo breast cancer recurrence experiment showed that the CSSH/Cur-Lip Gel inhibited breast cancer recurrence after tumors were resected, and the tissue of defect in CSSH/Cur-Lip Gel group was repaired. The results showed that the drug-loaded liposomal hydrogels can deliver curcumin continuously, and exerted an excellent tumoricidal effect in vitro and in vivo. The injectable, in-situ formable and thermosensitive CSSH/Cur-Lip Gel can be designed as a promising novel drug delivery vehicle to be used as carriers for local accurate and sustained drugs delivery to minimize burst release and as tissue engineering scaffolds for tissue regeneration after tumor resection.
- 25 March 2020
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 12 (15) , 17936-17948
Injectable and In Situ-Formable Thiolated Chitosan-Coated Liposomal Hydrogels as Curcumin Carriers for Prevention of In Vivo Breast Cancer Recurrence
In order to improve the water solubility and bioavailability, curcumin (Cur) was encapsulated by liposomes (Cur-Lip), which was further coated with thiolated chitosan (CSSH) to form liposomal hydrogels (CSSH/Cur-Lip Gel). The hydrogels were thermosensitive with in-situ injectable performance which were fluidic at room temperature and gelled quickly at 37 °C. The cumulative release ratio of 200 μM CSSH/Cur-Lip Gel were 31.57 ± 1.34 % at 12 h, which could effectively delay the release of curcumin. Worthily, the resilient hydrogels were compressive even after five cycles of compression. Cytotoxicity test indicated that the liposomal hydrogels had good cytocompatibility, but after encapsulation of curcumin, MCF-7 cells were suppressed and killed dramatically after 72 h. In vivo breast cancer recurrence experiment showed that the CSSH/Cur-Lip Gel inhibited breast cancer recurrence after tumors were resected, and the tissue of defect in CSSH/Cur-Lip Gel group was repaired. The results showed that the drug-loaded liposomal hydrogels can deliver curcumin continuously, and exerted an excellent tumoricidal effect in vitro and in vivo. The injectable, in-situ formable and thermosensitive CSSH/Cur-Lip Gel can be designed as a promising novel drug delivery vehicle to be used as carriers for local accurate and sustained drugs delivery to minimize burst release and as tissue engineering scaffolds for tissue regeneration after tumor resection.
- 1 February 2020
- Published by Elsevier in Carbohydrate Polymers
- Vol. 230, 115710
Histatin1-modified thiolated chitosan hydrogels enhance wound healing by accelerating cell adhesion, migration and angiogenesis
- 1 February 2020
- Published by Elsevier in Carbohydrate Polymers
- Vol. 230, 115710
Histatin1-modified thiolated chitosan hydrogels enhance wound healing by accelerating cell adhesion, migration and angiogenesis